The influence of industry over your health

Has Eisai forgotten the UK?

In the fourth part of our investigation into the Miracle Biologic Lecanemab, we disclosed that the US based Alzheimer’s Association received over $750,000 from Eisai in 2023. 

Investigating the Miracle Biologic Lecanemab for Alzheimer's Disease - Part 4

Writing in the Guardian, Margaret McCartney highlighted that doctors seldom truly comprehend the extent of industry influence.

‘Data published by the Association of the British Pharmaceutical Industry (APBI) shows that almost £42m was paid to UK health professionals in 2023 – a mix of mainly consultancy, travel and conference fees. Pharma clearly thinks a massive spend is a good idea.’

The ABPI requires the industry to publish annual lists of payments to patient organisations that you can search.

In 2023, Eisai Ltd. paid out £4.47 million in the UK, of which just over £243,000 was paid to 157 healthcare professionals. Unlike McCartney, we believe these doctors fully comprehend their actions; they simply choose not to acknowledge them. What's more critical, however, is that Eisai knows they are purchasing influence a…